Video

Identifying 3 major risk factors for AMD

Author(s):

OT Staff Reports

Joshua Mali, MD, discusses the three major risk factors for developing age-related macular degeneration (AMD).

Joshua Mali, MD, president of the Macular Degeneration Association, vitreoretinal surgeon at The Eye Associates (Sarasota, FL), discusses the three major risk factors for developing age-related macular degeneration (AMD).


See more AMD Awareness content here, here, and here.

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
Related Content
CHMP issues positive opinion for the marketing authorization of FYB203, a biosimilar candidate to aflibercept
November 23rd 2024

CHMP issues positive opinion for the marketing authorization of FYB203, a biosimilar candidate to aflibercept

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Integrating imaging modalities for early detection of key microscopic abnormalities in diabetic retinopathy
November 22nd 2024

Integrating imaging modalities for early detection of key microscopic abnormalities in diabetic retinopathy

EyePod podcast: Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)
November 1st 2024

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

Adverum Biotechnologies announces topline 52-week results from LUNA Phase 2 trial and 4-year OPTIC results
November 21st 2024

Adverum Biotechnologies announces topline 52-week results from LUNA Phase 2 trial and 4-year OPTIC results

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy
November 21st 2024

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy

© 2024 MJH Life Sciences

All rights reserved.